U.S., Nov. 6 -- ClinicalTrials.gov registry received information related to the study (NCT07918989) titled 'A Study of Different Skin Care Approaches to Prevent Skin Reactions in People With Breast Cancer Receiving Radiation Therapy After Mastectomy' on Oct. 30.
Brief Summary: The purpose of this study is to find out which of three standard skin care approaches works best to prevent a skin reaction called radiation dermatitis (redness, irritation, or breakdown of the skin) in people receiving radiation therapy after mastectomy.
Study Start Date: Oct. 30
Study Type: INTERVENTIONAL
Condition:
Breast Cancer
Breast Cancer Female
Intervention:
DRUG: Mometasone Furoate 1% Cream
Mometasone Furoate 1% Cream is a topical corticosteroid cream...